AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 Innovations in Cell, Gene, and Protein Therapies, Regenerative Medicine, Synthetic Biology, Epitranscriptomics, and CRISPR Editing - ResearchAndMarkets.com

April 16, 2019

DUBLIN--(BUSINESS WIRE)--Apr 16, 2019--The “Innovations in Cell, Gene, and Protein Therapies, Regenerative Medicine, Synthetic Biology, Epitranscriptomics, and CRISPR Editing” report has been added to ResearchAndMarkets.com’s offering.

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) details technology innovations across cell and gene therapies, regenerative medicine, synthetic biology, epitranscriptomics, CRISPR editing, biological computing, multiplexed assay and liquid biopsy platforms.

It also comprises emerging developments across mass spectrometry, vaccines, protein therapies, transplantation techniques, small molecule, and organ-on-a-chip technologies.

Key Topics Covered

  • Cartherics
  • Immuno-therapy
  • Cell Therapies
  • Cynata Therapeutics
  • Mesoblast
  • Orthocell
  • AMSilk
  • VLPbio
  • David H. Koch Institute for Integrative Cancer Research at MIT
  • Gotham Therapeutics
  • Beam Therapeutics
  • IQVIA
  • Microsoft
  • OMass Therapeutics
  • Nightstar Therapeutics
  • University of Minnesota
  • SpeeDx Diagnostics
  • Medicago
  • Mammoth Biosciences
  • Guardant Health
  • Horizon Pharma
  • Paragonix Technologies
  • Immunomedics
  • Achieve Life Sciences
  • Neurocrine Biosciences
  • InSphero
  • Bio-Rad
  • Key Contacts

For more information about this report visit https://www.researchandmarkets.com/r/rozpgj

View source version on businesswire.com:https://www.businesswire.com/news/home/20190416005771/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology,Genomics,Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/16/2019 11:12 AM/DISC: 04/16/2019 11:12 AM

http://www.businesswire.com/news/home/20190416005771/en